Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis

Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis - GRAMS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031139

Enrollment

1000

Registered

2023-01-26

Start date

2021-07-15

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis

Interventions

Group 1: There are no arms - Currently a cohort study (observational) to generate a database of deeply phenotyped MS patients.

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis Multiple Sclerosis or other demyelinating diseases of the CNS

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
There are no endpoints - cross-sectional survey to generate a database of deeply phenotyped MS patients.	—

Countries

Germany

Contacts

Public ContactSvea-Solveig Mennen

Max-Planck-Institut für Multidisziplinäre Naturwissenschaften

svea.mennen@mpinat.mpg.de+49-551-201-31114

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026